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Abstract 
The precautionary principle is part of evidence-based healthcare and is used both preventively and 
therapeutically when there is no available evidence about how to manage problems/diseases/conditions that 
are especially life-threatening. However, since it is not always based in the most qualified evidence, it is 
frequently questioned. The emergence of a highly contagious disease, with increased levels of 
morbimortality, an acute respiratory syndrome, the so called Coronavirus Disease 2019 (COVID-19), led 
health professionals to look for the best alternatives to save lives. In this sense, the precautionary principle 
was evocated. The aim of this paper is to make a reflection about the precautionary principle, the dental 
profession and COVID-19. It is important to have in mind that in such a disease, guidelines, protocols and 
approaches can change very fast, since a continuous evaluation of all policies is mandatory. During the 
pandemic, elective procedures may be restricted, but international organizations removed the 
recommendation to postpone elective procedures. Clinicians are advised to be updated about their local 
current policies. On the other hand, there are cases in which in-office dental care is unavoidable, such as 
individuals with pain, spontaneous bleeding and dental trauma. Biosafety is upmost importance when 
seeking patients during pandemic. In this sense, it was concluded that precautionary principle should be, 
therefore, used. However, caution needs to be taken and continuous surveillance necessary. 
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Introduction 
Evidence-based healthcare has been considered the current paradigm for all health professions [1]. 
This movement started with evidence-based medicine and spread for all health approaches. In such paradigm, 
the best available evidence should be used to treat individuals. This means that the so-called authority-based 
healthcare is increasingly questioned. Dentistry has a considerable difference from Medicine, since the majority 
of the situations faced by the profession does not have death as an outcome. Death is undoubtedly a true 
outcome. In Dentistry, with some exceptions, tooth loss is one of the most typical true outcomes [2]. Of 
course, patient-related outcome measures are also true outcomes (e.g., masticatory function, esthetics, oral 
health-related quality of life, among others) and have to be always considered. 
The paradigm of evidence-based dentistry combines three fundamental aspects: the best available 
evidence, the expertise of the professional and patient values and preferences. All of these aspects should be 
taken into consideration in the decision-making processes. 
However, there are some situations in which the best available evidence is of low quality or, even, 
inexistent. In 2020, a pandemic emerged: the Coronavirus Disease 2019 (COVID-19). It has been responsible 
for a very high number of deaths worldwide. The contamination with the SARS-CoV-2 (coronavirus) generates 
a strong respiratory syndrome, which, especially for older adults and for those with chronic diseases, has a high 
mortality rate [3]. Therefore, different preventive and therapeutic measures have been advocated. Some of the 
measures are not based on high-quality evidence and others might even not have any support. Their indication 
is frequently based in the so-called precautionary principle [4]. The present article aims at making a deep 
thought about the precautionary principle in dental care, especially taking into consideration the COVID-19 
pandemic. 
 
The Precautionary Principle – Definition and Reflections 
The precautionary principle is a preventive concept. Traditionally, it comes from epidemiological 
studies that identify potential risk factors and, even without the complete proof, start to be part of the 
preventive policies [4]. It is used when the evidence neither clearly supports nor refutes the hypothesis. Of 
course, the inclusion of action on the preventive policy needs to be under continuous and close surveillance, up 
to the moment in which the evidence supports or discards the measure. Figure 1 summarizes the precautionary 
principle in the context of evidence-based healthcare. 
 
 
 
Figure 1. Summary of the evidence-based healthcare and precautionary principle. 
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A very important situation in the use of the precautionary principle is that adverse events are also 
taken into consideration [5]. Moreover, the nature and morbimortality of the situation under consideration is 
of utmost importance. The precautionary principle is much more useful in situations in which morbimortality 
is high, which is specifically the case with COVID-19 [4]. 
In addition to preventive measurements, the precautionary principle is useful in therapeutic 
approaches. For example, in some types of cancer, therapy starts to be used even before statistically significant 
differences are observed in comparison to a control group [6]. However, in such situations, in the same 
manner, that in preventive approaches, a close surveillance of the positive and negative effects is mandatory. 
It is very important that the one’s understanding, advocating or even analyzing the precautionary 
principle are aware of the fact that uncertainty is present in these situations in various levels [4]. Evidence-
based healthcare tries to rule out uncertainty with the best possible means; however, when life is threatened, 
higher levels of uncertainty need to be tolerated. 
In this respect, one situation that needs to be strengthened is that the “absence of evidence is not 
evidence of absence”. This means that when you do not have evidence in a specific situation, it does not support 
that this situation is useless or does not work [5]. This is a very popular epidemiological sentence that needs 
to be always taken into consideration both in the decision-making process as well as in the planning and 
censuring of research projects. Sometimes it is not ethical not to perform a study, if there is no evidence to it, 
just because of an individual’s belief. So, the precautionary principle is also used with proposals that will be 
accepted or refuted if continued under adequate surveillance [5]. 
On the other hand, one very important situation comes with the precautionary principle. This is: 
which is the outcome of the problem/disease/condition? If the outcome is death, high levels of handicap, or 
similar situations, evidence of less quality might support the approaches until a definitive answer is achieved 
[4]. However, this is not adequate if the problem/disease/condition does not have a very harmful outcome. In 
Dentistry, the precautionary principle is, therefore, very limited [5]. One argument frequently comes into the 
picture: “if it does not harm, why not to use it?”.  This is completely inadequate in evidence-based healthcare 
unless specific reasons are raised to use the precautionary principle [4]. 
Several points of view are extremely critical to the precautionary principle, especially due to the 
misuse of it. Some reports even put it in a perspective of a scientific fallacy or incoherence [7]. Clearly, this is 
not a situation that has only one side. A more comprehensive understanding of the principle is mandatory, with 
a critical analysis of every situation involving the precautionary principle [6]. 
 
An Analysis of COVID-19 
The pandemic of COVID-19 probably started in China and has spread worldwide [8]. This is a highly 
contagious disease that inputs high levels of uncertainty for healthcare professionals. This is mainly related to 
the fact that it is a new disease and lack of knowledge exacerbates the situation. 
The present study was written between May 20th and June 5th, 2020. This is of high importance to be 
highlighted, since even during this 2-week interval, several situations changed and the information is being 
updated sometimes more than once a day. It is known that the pandemic has reached all continents of the 
world and that in absolute numbers of death, the United States of America and Brazil are the countries with 
high figures [9,10]. It is estimated that more than 370 thousand people died worldwide up to the end of May 
2020 and that the number of infected people is of more than 6.2 million [11]. One study estimated that the 
prevalence of risk factors to severe COVID-19 range between 34% to 54.4% among Brazilian adults, when 
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different criteria are considered [12]. Moreover, São Paulo (range: 35.6% to 58.2%), Rio de Janeiro (range: 36% 
to 55.8%), Minas Gerais (range: 35.6% to 55.1%) and Rio Grande do Sul (range: 39.5% to 58.4%) are the 
Brazilian states that demonstrated the highest prevalence of at least one risk factor for severe COVID-19 [12]. 
Research is emerging from different countries and it seems that keeping social distance is one of the 
measurements that decreases infectivity [13]. This is also of importance, since a flattening of the curve may be 
possible, allowing the health systems to get prepared to it. Together with the uncertainty of any kind of 
approach comes the need for governmental investment worldwide, which elicits high levels of polemics.  
The World Health Organization is trying to lead the understanding process of the pandemic and has 
already declared that we are facing a public health emergency, with the need of conjunct efforts from every 
citizen of every country [11]. Based on the precautionary principle (since no evidence was available for this 
specific disease), different protective measures utilized collateral evidence trying to protect the populations and 
the continuous evaluation of such measurements constitutes the current best available evidence. 
As in any situation in evidence-based healthcare, the methods used to evaluate anything are essential. 
In this respect, data on prevalence is not available. This is due to the fact that different countries have different 
protocols for testing individuals, different ways of counting for death causes, etc. Probably, a significant 
number of deaths by COVID-19 were not reported as such, especially due to under notification or even due to 
lack of testing of the dead individuals. 
Some countries with more established healthcare systems have better forms of notifications. For 
example, in the United States of America, a public-private partnership for community-based testing is 
happening [14]. In Germany, there is a private partnership with laboratories and all healthcare facilities to 
provide as much COVID-19 tests as possible [15]. 
One point that needs to be analyzed is that associations between some measures and elevation or 
flattening of the disease curve are available. Social isolation has been demonstrated to be effective [13]. The 
use of masks has been proposed [16], but the World Health Organization does not recommend the use of mask 
for healthy individuals, except for health workers or for individuals with direct contact with a sick person [17]. 
CDC recommends the use of cloth face coverings associated with hand washing, or hand sanitizer with at least 
60% alcohol, social distancing (at least 1.8m), clean and disinfection of surfaces [18]. 
Another interesting situation that cannot be forgotten is that a hypothesis of a possible positive effect 
of chloroquine and hydroxychloroquine in patients with COVID-19 was raised. This was the first hypothesis 
that led to a wrong understanding by parts of the healthcare systems. If in one hand a possible interesting 
effect was demonstrated, on the other the evidence was very weak and mainly observational. After some weeks 
of usage by those that understood the potential benefits would be worth, studies are not confirming such 
benefit. On the contrary, it seems that the posed risks are very high [19]. Therefore, in a very short period of 
time, higher quality evidence transformed a possibility of treatment in an inadequate approach. 
The reality is that we are facing an unknown disease, with a high level of mortality and that direct 
qualified evidence is not available neither for prevention nor for treatment. In this respect, taking into 
consideration the idea of the precautionary principle, measures based on collateral evidence might be taken and 
need continuous evaluation in order to, if proven consistently beneficial, become part of established protocols 
and, in case of not a proven benefit or a demonstration of important adverse effects, to be banned from the 
strategies. 
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The Precautionary Principle, COVID-19 and Oral Care 
In the context of COVID-19, Dentistry is facing a new challenge. Similarly to professionals that work 
in intubation of infected patients, dental professionals deal with an important situation regarding aerosol. 
Saliva is contaminated and a source of infection both for health professionals as well as for other patients that 
are in the same environment. The literature also suggests that salivary glands could be a potential reservoir for 
the virus [20]. 
Also, it should be highlighted that elective procedures should be limited at this point in the pandemic. 
This means that maintenance visits, for example, are probably postponed. Despite that, Center of Diseases 
Control and Prevention (CDC) (USA) removed the recommendation to postpone elective procedures in May 
18th [21]. In Brazil, there are different recommendations, varying for each state. Clinicians must be updated 
about the local current policies [22,23]. They all depend on the numbers of infected people and the capacity of 
the health system. 
One important information that has to be given for the population is that oral hygiene methods should 
be even emphasized, in order to avoid, to the best possible means, the necessity of urgent dental care or, even, 
deterioration of oral health [24]. 
On the other hand, there are cases in which in-office dental care is unavoidable, such as individuals 
with pain, spontaneous bleeding, dental trauma, etc. [24]. In these situations, biosafety is fundamental. In this 
respect, Dentistry has a lot to teach other professions. However, traditional biosafety measurements are 
probably not enough. Hence, evidence-based approaches should be preferred. Moreover, part of the decisions 
will not be evidence-based or, at least, not based on the best quality evidence. But one has to decide and, taking 
into consideration the best available direct or collateral evidence, guidelines should be constructed. 
Different organizations have worked on this topic and, up to the moment of the present article, some 
recommendations were made by them. CDC and ADA recommendations include previous contact with the 
patients for COVID-19 screening, avoid non-emergent dental care when the patient has COVID-19 symptoms, 
limit the number of companions whenever possible, minimize the number of patients in the waiting room and 
check the patient's temperature before dental care [21,25]. 
One rapid systematic review identified produced guidance and reports that presented 
recommendations from international organizations and professional bodies on the current requirements for the 
re-opening of dental services [26]. This study summarized that face mask and eye wear protection 
(glasses/googles, face shields) are indicated to all staff as personal protective equipment (PPE) [26]. The use 
of dedicated working uniform and single use gloves are also pointed out. Regarding post-operative cleaning, it 
is recommended that all surfaces must be cleaned and disinfected following every patient, and the clinical floor 
must be cleaned from 2 to 3 times per day [26]. This disinfection may be performed with 
hypochlorite/chlorine based solutions or with 60-70% alcohol. Furthermore, clinical waste must be disposed of 
as per regulations of local system. The disposal of PPE and other disposable contaminated materials are 
recommended to be placed in a hard-lid container [26]. 
One example of the included suggested procedures is rinsing with H2O2. For this suggestion, direct 
evidence is not available. The potential of H2O2 in reducing viral load is an example of the use of the 
precautionary principle. However, this needs continuous evaluation. 
Since evidence-based Dentistry also relies on patient participation, it is very important to clearly 
inform the individuals seeking dental care about the whole situation and have it in a signed written informed 
consent. 
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Conclusion 
In the moment of the writing of the present article, very little high-quality evidence was available for 
prevention and treatment of COVID-19. The precautionary principle should be, therefore, used. However, 
caution needs to be taken and continuous surveillance necessary. Science has to be mature to take steps further 
and steps back, with the main aim of healthcare, which is the well-being of humanity. 
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